Tokyo Tape
Sign in
← Medinet

Quarterly report · Q3

2370.TEDINET S100RNR9
Period2022-10-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥492m2022-10-01 → 2023-06-30StandaloneNet sales
Revenue¥634m2021-10-01 → 2022-09-30StandaloneNet sales (5-year summary)
Revenue¥470m2021-10-01 → 2022-06-30StandaloneNet sales
Operating income−¥1.0bn2022-10-01 → 2023-06-30StandaloneOperating income
Operating income−¥988m2021-10-01 → 2022-06-30StandaloneOperating income
Ordinary income−¥1.0bn2022-10-01 → 2023-06-30StandaloneOrdinary income
Ordinary income−¥1.3bn2021-10-01 → 2022-09-30StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥984m2021-10-01 → 2022-06-30StandaloneOrdinary income
Profit before tax−¥1.0bn2022-10-01 → 2023-06-30StandaloneIncome before income taxes
Profit before tax−¥985m2021-10-01 → 2022-06-30StandaloneIncome before income taxes
Net income−¥1.0bn2022-10-01 → 2023-06-30StandaloneProfit loss
Net income−¥1.3bn2021-10-01 → 2022-09-30StandaloneNet income loss (5-year summary)
Net income−¥989m2021-10-01 → 2022-06-30StandaloneProfit loss
Total assets¥5.5bnat 2023-06-30StandaloneAssets
Total assets¥6.1bnat 2022-09-30StandaloneAssets
Total assets¥6.3bnat 2022-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥564mat 2023-06-30StandaloneLiabilities
Total liabilities¥566mat 2022-09-30StandaloneLiabilities
Net assets / equity¥5.0bnat 2023-06-30StandaloneNet assets
Net assets / equity¥5.5bnat 2022-09-30StandaloneNet assets
Net assets / equity¥5.7bnat 2022-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥4.1bnat 2023-06-30StandaloneCash and deposits
Cash and deposits¥4.5bnat 2022-09-30StandaloneCash and deposits
EPS (basic)¥-4.92022-10-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.72023-04-01 → 2023-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.332021-10-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-5.112021-10-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.52022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio89.3%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.7%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio91.4%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued219,986,757at 2023-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued211,730,423at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued211,730,423at 2022-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-06-30−¥445m
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2022-10-01 → 2023-06-30¥358,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2022-10-01 → 2023-06-30¥358,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2022-10-01 → 2023-06-30−¥359m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2022-10-01 → 2023-06-30¥492m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2022-10-01 → 2023-06-30¥492m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2022-10-01 → 2023-06-30−¥242m
—segment totalrevenue2022-10-01 → 2023-06-30¥492m
—segment totalrevenue external2022-10-01 → 2023-06-30¥492m
—segment totalsegment profit2022-10-01 → 2023-06-30−¥601m
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-06-30−¥386m
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2021-10-01 → 2022-06-30¥194,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2021-10-01 → 2022-06-30¥194,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2021-10-01 → 2022-06-30−¥425m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2021-10-01 → 2022-06-30¥470m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2021-10-01 → 2022-06-30¥470m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2021-10-01 → 2022-06-30−¥178m
—segment totalrevenue2021-10-01 → 2022-06-30¥470m
—segment totalrevenue external2021-10-01 → 2022-06-30¥470m
—segment totalsegment profit2021-10-01 → 2022-06-30−¥603m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 321
ItemContextValueUnit
Accounts payable tradeCurrentQuarterInstant_NonConsolidatedMember39607000JPY
Income taxes payablePrior1YearInstant_NonConsolidatedMember28746000JPY
Income taxes payableCurrentQuarterInstant_NonConsolidatedMember6537000JPY
Provision for bonusesPrior1YearInstant_NonConsolidatedMember57016000JPY
Provision for bonusesCurrentQuarterInstant_NonConsolidatedMember29819000JPY
Other clPrior1YearInstant_NonConsolidatedMember147408000JPY
Other clCurrentQuarterInstant_NonConsolidatedMember181155000JPY
Current liabilitiesPrior1YearInstant_NonConsolidatedMember279313000JPY
Current liabilitiesCurrentQuarterInstant_NonConsolidatedMember257119000JPY
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember156160000JPY
Asset retirement obligations nclCurrentQuarterInstant_NonConsolidatedMember157647000JPY
Provision for share based payments nclPrior1YearInstant_NonConsolidatedMember－JPY
Provision for share based payments nclCurrentQuarterInstant_NonConsolidatedMember12963000JPY
Other nclPrior1YearInstant_NonConsolidatedMember130662000JPY
Other nclCurrentQuarterInstant_NonConsolidatedMember136233000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember286822000JPY
Noncurrent liabilitiesCurrentQuarterInstant_NonConsolidatedMember306844000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember566136000JPY
LiabilitiesCurrentQuarterInstant_NonConsolidatedMember563964000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember5892020000JPY
Capital stockCurrentQuarterInstant_NonConsolidatedMember5426174000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember1360593000JPY
Capital surplusCurrentQuarterInstant_NonConsolidatedMember267193000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-2093633000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember-1045052000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-2000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-4000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember5158978000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember4648310000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember352946000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember305568000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember352946000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember305568000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember－JPY
Subscription rights to sharesCurrentQuarterInstant_NonConsolidatedMember27939000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember5511924000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember4981819000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember6078061000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember5545783000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember469785000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember491922000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember380060000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember421869000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember89725000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember70052000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember1078131000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember1116418000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-988406000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-1046366000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember5075000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-09-30pass rounding
balance sheet identitynon_consolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · net assetsnon_consolidated 2023-06-30pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2022-10-01/2023-06-30pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass
statement vs summary · total assetsnon_consolidated 2023-06-30pass